FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023188616> ?p ?o ?g. }

• W2023188616 endingPage "1147" @default.
• W2023188616 startingPage "1137" @default.
• W2023188616 abstract "Objective: To evaluate the long-term efficacy of immunosuppressive therapy on Immunoglobulin A nephropathy (IgAN).Methods: Trials with at least 5-year follow-up investigating immunosuppressive therapy were selected.Main outcome measures: Primary outcome was end-stage renal disease (ESRD). Secondary outcome was deterioration in renal function defined as doubled serum creatinine or 50% reduction of eGFR.Results: Seven studies were enrolled. Immunosuppression lowered the risk for ESRD risk ratio (RR = 0.30, 95% CI 0.19 – 0.48, p < 0.00001) and deterioration in renal function (RR = 0.19, 95% CI 0.07 – 0.54, p = 0.002). As for pooled RRs of ESRD, there were four studies with < 7-year follow-up, three followed for > 7 years, four adopted corticosteroids, two used corticosteroids plus other immunosuppressive agents, four were from Asia, and three from Europe. Pooled RRs were 0.32 (95% CI, 0.18 – 0.58, p = 0.0001), 0.28 (95% CI, 0.13 – 0.59, p = 0.0009), 0.34 (95% CI, 0.17 – 0.67, p = 0.002), 0.29 (95% CI, 0.15 – 0.58, p = 0.0005), 0.37 (95% CI, 0.20 – 0.68, p = 0.001) and 0.23 (95% CI, 0.11 – 0.47, p < 0.0001), respectively. Immunosuppression was associated with an increased risk for adverse events (RR = 2.13, 95% CI 1.17 – 3.86, p = 0.01).Conclusions: Immunosuppressive therapy for IgAN might reduce long-term risk of ESRD and deterioration in renal function but increase risk of adverse events, and the efficacy on patients from Europe and Asia might be similar. Addition of other immunosuppressive agents did not provide additional benefit." @default.
• W2023188616 created "2016-06-24" @default.
• W2023188616 creator A5037338561 @default.
• W2023188616 creator A5041382816 @default.
• W2023188616 creator A5047455686 @default.
• W2023188616 creator A5047478552 @default.
• W2023188616 creator A5050487837 @default.
• W2023188616 creator A5058055057 @default.
• W2023188616 creator A5065243448 @default.
• W2023188616 creator A5091641134 @default.
• W2023188616 date "2015-04-20" @default.
• W2023188616 modified "2023-09-22" @default.
• W2023188616 title "The long-term efficacy and safety of immunosuppressive therapy on the progression of IgA nephropathy: a meta-analysis of controlled clinical trials with more than 5-year follow-up" @default.
• W2023188616 cites W1574743301 @default.
• W2023188616 cites W1947493474 @default.
• W2023188616 cites W1966209628 @default.
• W2023188616 cites W1995850259 @default.
• W2023188616 cites W1997948783 @default.
• W2023188616 cites W2002051261 @default.
• W2023188616 cites W2026103095 @default.
• W2023188616 cites W2032354231 @default.
• W2023188616 cites W2054418276 @default.
• W2023188616 cites W2085126429 @default.
• W2023188616 cites W2089876742 @default.
• W2023188616 cites W2096977413 @default.
• W2023188616 cites W2100076924 @default.
• W2023188616 cites W2101763206 @default.
• W2023188616 cites W2105803357 @default.
• W2023188616 cites W2107238505 @default.
• W2023188616 cites W2107793847 @default.
• W2023188616 cites W2125785855 @default.
• W2023188616 cites W2139030893 @default.
• W2023188616 cites W2151689843 @default.
• W2023188616 cites W2157823046 @default.
• W2023188616 cites W2161464792 @default.
• W2023188616 cites W2161627792 @default.
• W2023188616 cites W2162337442 @default.
• W2023188616 cites W2594454279 @default.
• W2023188616 cites W4241655994 @default.
• W2023188616 doi "https://doi.org/10.1517/14656566.2015.1038238" @default.
• W2023188616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25892092" @default.
• W2023188616 hasPublicationYear "2015" @default.
• W2023188616 type Work @default.
• W2023188616 sameAs 2023188616 @default.
• W2023188616 citedByCount "9" @default.
• W2023188616 countsByYear W20231886162016 @default.
• W2023188616 countsByYear W20231886162017 @default.
• W2023188616 countsByYear W20231886162018 @default.
• W2023188616 countsByYear W20231886162019 @default.
• W2023188616 countsByYear W20231886162021 @default.
• W2023188616 countsByYear W20231886162022 @default.
• W2023188616 crossrefType "journal-article" @default.
• W2023188616 hasAuthorship W2023188616A5037338561 @default.
• W2023188616 hasAuthorship W2023188616A5041382816 @default.
• W2023188616 hasAuthorship W2023188616A5047455686 @default.
• W2023188616 hasAuthorship W2023188616A5047478552 @default.
• W2023188616 hasAuthorship W2023188616A5050487837 @default.
• W2023188616 hasAuthorship W2023188616A5058055057 @default.
• W2023188616 hasAuthorship W2023188616A5065243448 @default.
• W2023188616 hasAuthorship W2023188616A5091641134 @default.
• W2023188616 hasConcept C126322002 @default.
• W2023188616 hasConcept C134018914 @default.
• W2023188616 hasConcept C159641895 @default.
• W2023188616 hasConcept C197934379 @default.
• W2023188616 hasConcept C2778653478 @default.
• W2023188616 hasConcept C2780252810 @default.
• W2023188616 hasConcept C2781184683 @default.
• W2023188616 hasConcept C44249647 @default.
• W2023188616 hasConcept C555293320 @default.
• W2023188616 hasConcept C71924100 @default.
• W2023188616 hasConcept C82789193 @default.
• W2023188616 hasConcept C90924648 @default.
• W2023188616 hasConcept C95190672 @default.
• W2023188616 hasConceptScore W2023188616C126322002 @default.
• W2023188616 hasConceptScore W2023188616C134018914 @default.
• W2023188616 hasConceptScore W2023188616C159641895 @default.
• W2023188616 hasConceptScore W2023188616C197934379 @default.
• W2023188616 hasConceptScore W2023188616C2778653478 @default.
• W2023188616 hasConceptScore W2023188616C2780252810 @default.
• W2023188616 hasConceptScore W2023188616C2781184683 @default.
• W2023188616 hasConceptScore W2023188616C44249647 @default.
• W2023188616 hasConceptScore W2023188616C555293320 @default.
• W2023188616 hasConceptScore W2023188616C71924100 @default.
• W2023188616 hasConceptScore W2023188616C82789193 @default.
• W2023188616 hasConceptScore W2023188616C90924648 @default.
• W2023188616 hasConceptScore W2023188616C95190672 @default.
• W2023188616 hasIssue "8" @default.
• W2023188616 hasLocation W20231886161 @default.
• W2023188616 hasLocation W20231886162 @default.
• W2023188616 hasOpenAccess W2023188616 @default.
• W2023188616 hasPrimaryLocation W20231886161 @default.
• W2023188616 hasRelatedWork W1885119863 @default.
• W2023188616 hasRelatedWork W2168373821 @default.
• W2023188616 hasRelatedWork W2318187771 @default.
• W2023188616 hasRelatedWork W2413205046 @default.
• W2023188616 hasRelatedWork W2592774827 @default.
• W2023188616 hasRelatedWork W2614276645 @default.
• W2023188616 hasRelatedWork W2626084264 @default.

• next